Momentum Momentum Momentum

Momentum rotation to hit technology and financials

Equities 8 minutes to read
PG
Peter Garnry

Head of Equity Strategy

Summary:  The biggest momentum ETF in the US is about to rebalance and based on the current momentum factor scores technology and financial stocks are going to be cut with the biggest effect on the biggest index weight names such as JPMorgan Chase, Tesla, Microsoft, and Bank of America. Momentum strategies are adjusting to the new trend of value stocks suddenly being where momentum is and this rotation could add to the selling pressure in technology stocks. Tesla has also recently been kicked out of the S&P ESG Index and thus multiple funds will likely soon begin reducing Tesla shares.


The biggest rotation on record in momentum funds is coming

According to a recent Wells Fargo research note, the $9.8bn momentum fund iShares MSCI USA Momentum Factor ETF (MTUM) could be on its way to make its biggest rotation on record due to a dramatic shift in the momentum factor away from information technology and financials, and into health care, consumer staples and energy stocks. MTUM is down 28% mimicking the downfall of the Nasdaq 100 underscoring the overlap between the momentum factor and the recent years of technology outperformance, and now the unwinding of that alpha.

Based on the MSCI’s methodology behind the momentum factor we calculated the combined momentum score for the 30 largest positions in the MTUM fund. As the table shows, stocks such as BlackRock (what an irony being the owner of the fund itself), Goldman Sachs, Adobe, Alphabet, Oracle, Moderna, Bank of America, and JPMorgan Chase are some of the big losers. The winners are Eli Lilly, Costco (not for long with carnage in US retailing), ConocoPhillips, EOG Resources, Devon Energy, and Occidental Petroleum. But momentum in Tesla and Microsoft has also faded and will be reduced upon the next rebalancing, and due to the momentum factor methodology those with the highest underlying weight in the index (in this cases the MSCI USA Index) will be hit harder.

Source: Bloomberg

This week Tesla was also removed from S&P’s ESG Index due to the company lacking on the S and G driven by questionable working conditions at its factories and investigations related to accidents with its autopilot, according to the S&P statement. Other ESG funds are still holding Tesla, but the tide is shifting and Tesla could experience more selling from ESG funds going forward. Combined with the momentum rotation this could lead to a sizeable selling from multiple funds. Momentum strategies come in many different shapes and across private accounts, advisory accounts, ETFs, mutual funds, hedge funds etc. and thus the combined rotation is a lot bigger than the MTUM would suggest.

The momentum factor explained

The MSCI Momentum Factor methodology is defined in this paper and is basically a combined measure of the 6-month and 12-month price momentum (that is total return over that period), where the last month is removed due to short-term mean-reversion effects in the market (what has risen a lot recently tends to go down the following month). These raw measures of momentum is then standardized using the annualized volatility of the stock using 3 years of weekly observations. This combined momentum score is then further standardized to a Z-score which is then winsorized to 3 or -3 which means that any value above or below 3 or -3 are capped at these thresholds. This avoids dramatic outliers to cause a big weight change which is costly for the fund and very high Z-score values would most likely be noise anyway. These Z-scores are then turned into a momentum score which is multiplied by the underlying weight in the tracking index and then normalized to 100%, so the fund becomes a long-only fund with 100% investment. This means that a dramatic shift in the momentum score for those stocks with a large weight in the underlying will get increased or decreased in an amplified manner.

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.